Steven Cohen's MRK Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.26 M shares of Merck & Co., Inc. (MRK) worth $105.98 M, representing 0.18% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in MRK, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2020, adding 3.77 M shares. Largest reduction occurred in Q2 2022, reducing 2.39 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Merck & Co (MRK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Merck & Co (MRK) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +18,027 | Add 0.00% | 18,026 | $55.20 |
| Q3 2014 | +318,487 | Add 1766.82% | 336,513 | $56.57 |
| Q4 2014 | -9,956 | Reduce 2.96% | 326,557 | $54.19 |
| Q1 2015 | -245,023 | Reduce 75.03% | 81,534 | $54.85 |
| Q2 2015 | -81,534 | Sold Out | 0 | $0.00 |
| Q3 2016 | +188,430 | New Buy | 188,430 | $59.55 |
| Q4 2016 | -188,430 | Sold Out | 0 | $0.00 |
| Q1 2017 | +162,440 | New Buy | 162,440 | $60.63 |
| Q2 2017 | -23,790 | Reduce 14.65% | 138,650 | $61.15 |
| Q3 2017 | +821,270 | Add 592.33% | 959,920 | $61.10 |
| Q4 2017 | -959,920 | Sold Out | 0 | $0.00 |
| Q1 2018 | +1.82 M | New Buy | 1.82 M | $51.97 |
| Q2 2018 | -648,893 | Reduce 35.57% | 1.18 M | $57.92 |
| Q3 2018 | -1.18 M | Sold Out | 0 | $0.00 |
| Q4 2019 | +590,054 | New Buy | 590,054 | $86.78 |
| Q1 2020 | -590,054 | Sold Out | 0 | $0.00 |
| Q2 2020 | +3.77 M | New Buy | 3.77 M | $73.79 |
| Q3 2020 | -2.15 M | Reduce 57.09% | 1.62 M | $79.15 |
| Q4 2020 | +73,400 | Add 4.54% | 1.69 M | $78.05 |
| Q1 2021 | -35,095 | Reduce 2.08% | 1.66 M | $73.56 |
| Q2 2021 | -123,440 | Reduce 7.45% | 1.53 M | $77.77 |
| Q3 2021 | +853,900 | Add 55.72% | 2.39 M | $75.11 |
| Q4 2021 | -2.33 M | Reduce 97.81% | 52,149 | $76.65 |
| Q1 2022 | +3.53 M | Add 6768.78% | 3.58 M | $82.05 |
| Q2 2022 | -2.39 M | Reduce 66.60% | 1.2 M | $91.17 |
| Q3 2022 | -601,600 | Reduce 50.28% | 594,800 | $86.12 |
| Q4 2022 | -241,927 | Reduce 40.67% | 352,873 | $110.95 |
| Q1 2023 | +274,099 | Add 77.68% | 626,972 | $106.39 |
| Q2 2023 | +34,122 | Add 5.44% | 661,094 | $115.39 |
| Q3 2023 | -402,742 | Reduce 60.92% | 258,352 | $102.95 |
| Q4 2023 | +1.45 M | Add 561.05% | 1.71 M | $109.02 |
| Q1 2024 | -1.71 M | Sold Out | 0 | $0.00 |
| Q2 2025 | +5,800 | New Buy | 5,800 | $79.16 |
| Q3 2025 | +1.26 M | Add 21671.60% | 1.26 M | $83.93 |
Steven Cohen's Merck & Co Investment FAQs
Steven Cohen first purchased Merck & Co., Inc. (MRK) in Q2 2014, acquiring 18,026 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Merck & Co., Inc. (MRK) for 34 quarters since Q2 2014.
Steven Cohen's largest addition to Merck & Co., Inc. (MRK) was in Q2 2020, adding 3,769,218 shares worth $278.12 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,262,753 shares of Merck & Co., Inc. (MRK), valued at approximately $105.98 M.
As of the Q3 2025 filing, Merck & Co., Inc. (MRK) represents approximately 0.18% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Merck & Co., Inc. (MRK) was 3,769,218 shares, as reported at the end of Q2 2020.